3.1. GPC6 and TMEM132D Are Differentially Expressed in TIL+ Early Stage Ovarian Cancer and Their Expression Levels Correlate with CD8+ T-Cell Infiltration. Here, TMEM132D is linked to ovarian carcinoma.